Form 8-K - Current report:
SEC Accession No. 0001477932-18-005263
Filing Date
2018-11-06
Accepted
2018-11-06 10:23:35
Documents
3
Period of Report
2018-11-06
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K pvotf_8k.htm 8-K 12910
2 10% SENIOR SECURED CONVERTIBLE DEBENTURE pvotf_ex1036.htm EX-10.36 162270
3 10% SENIOR SECURED CONVERTIBLE DEBENTURE pvotf_ex1037.htm EX-10.37 166049
  Complete submission text file 0001477932-18-005263.txt   342431
Mailing Address 1275 WEST 6TH AVENUE VANCOUVER A1 V6H 1A6
Business Address 1275 WEST 6TH AVENUE VANCOUVER A1 V6H 1A6 604 805 7783
Pivot Pharmaceuticals Inc. (Filer) CIK: 0001464165 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0131
Type: 8-K | Act: 34 | File No.: 333-161157 | Film No.: 181161865
SIC: 2834 Pharmaceutical Preparations